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Correction to:  Cancer Cell Int 20:444 (2020)  
https ://doi.org/10.1186/s1293 5-020-01531 
-1
Following publication of the original article [1], we were 
notified of a mistake in the spelling of the first author.
• Incorrect spelling: Mohammad Hossein Mehrzadi
• Correct spelling: Mohammad Hossein Pourhanifeh
The original article has been corrected.
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